吸入性损伤:未满足的临床需求与未来研究方向
本文为美国烧伤协会2018年工作组综述,总结吸入性损伤在诊断、病理生理和治疗方面的关键不足。指出其进展落后于皮肤热损伤,支气管镜诊断主观、缺乏生物标志物、插管决策紧急且药物与通气策略无统一推荐,并提出气道修复、微生物组和候选生物标志物三个重点研究方向。
要点
- 吸入性损伤诊断依赖主观支气管镜,缺乏诊断生物标志物。
- 插管决策紧急,黏液溶解剂、抗凝剂等应用无统一推荐。
- 未来研究重点:气道修复机制、气道微生物组、候选生物标志物。
核心结论
- 吸入性损伤诊治进展落后于皮肤热损伤,存在多项未满足的临床需求。
研究设计与样本
- 美国烧伤协会皮肤热损伤与吸入性损伤工作组2018年综述,总结诊断、病理生理和治疗现状。
主要发现
- 病理生理理解不足、支气管镜诊断困难且主观、缺乏诊断生物标志物。
- 插管决策紧急,黏液溶解剂、抗凝剂、支气管扩张剂及改良通气策略等无统一推荐。
临床怎么用
- 临床需认识吸入性损伤诊断与治疗的不确定性,关注气道修复、微生物组和生物标志物研究进展。
局限性
- 本文为综述,未提供原始研究数据或定量证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary and systemic insults from inhalation injury can complicate the care of burn patients and contribute to significant morbidity and mortality. However, recent progress in diagnosis and treatment of inhalation injury has not kept pace with the care of cutaneous thermal injury. There are many challenges unique to inhalation injury that have slowed advancement, including deficiencies in our understanding of its pathophysiology, the relative difficulty and subjectivity of bronchoscopic diagnosis, the lack of diagnostic biomarkers, the necessarily urgent manner in which decisions are made about intubation, and the lack of universal recommendations for the application of mucolytics, anticoagulants, bronchodilators, modified ventilator strategies, and other measures. This review represents a summary of critical shortcomings in our understanding and management of inhalation injury identified by the American Burn Association's working group on Cutaneous Thermal Injury and Inhalation Injury in 2018. It addresses our current understanding of the diagnosis, pathophysiology, and treatment of inhalation injury and highlights topics in need of additional research, including 1) airway repair mechanisms; 2) the airway microbiome in health and after injury; and 3) candidate biomarkers of inhalation injury.
引用
- Dyamenahalli K, Garg G, Shupp JW, et al. Inhalation Injury: Unmet Clinical Needs and Future Research. J Burn Care Res. 2019. PMID: 31214710. doi:10.1093/jbcr/irz055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。